Cargando…
CLRM-20 IDENTIFYING RISK FACTORS AND ANALYZING SURVIVAL FOLLOWING PACHYMENINGEAL FAILURE
OBJECTIVE: Neurosurgery (NS) is an essential modality for large brain metastases (BM). As an adjuvant treatment, stereotactic radiosurgery (SRS) reduces neurocognitive toxicity without affecting post-treatment overall survival (OS) compared to whole brain radiation therapy. Pachymeningeal failure (P...
Autores principales: | Kalyvas, Aristotelis, Gutierrez-Valencia, Enrique, Weiss, Jessica, O’ Halloran, Philip J, Mohan, Nilesh, Wong, Christine, Conrad, Tatiana, Millar, Barbara-Ann, Laperriere, Normand, Bernstein, Mark, Zadeh, Gelareh, Shultz, David, Kongkham, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354221/ http://dx.doi.org/10.1093/noajnl/vdac078.040 |
Ejemplares similares
-
MLTI-06. Surgical resection plus stereotactic radiosurgery versus SRS alone for large brain metastases: a comparative study
por: Gutierrez, Enrique, et al.
Publicado: (2021) -
MMAP-09 CHARACTERISTICS CORRELATING WITH SURVIVAL IN PATIENTS TREATED FOR LARGE BRAIN METASTASES
por: Gutierrez-Valencia, Enrique, et al.
Publicado: (2022) -
Multiplicity does not significantly affect outcomes in brain metastasis patients treated with surgery
por: Yang, Kaiyun, et al.
Publicado: (2022) -
SURG-13. Multiplicity does not affect outcomes in patients with surgically treated brain metastases
por: Yang, Kaiyun, et al.
Publicado: (2021) -
LITTing up Gliomas—Is the Future Bright?
por: O’Halloran, Philip J., et al.
Publicado: (2022)